Antiretroviral therapy initiation within 7 and 8-30 days post-HIV diagnosis demonstrates similar benefits in resource-limited settings

AIDS. 2022 Oct 1;36(12):1741-1743. doi: 10.1097/QAD.0000000000003327. Epub 2022 Jul 9.

Abstract

We estimated the optimum time to initiate antiretroviral therapy (ART) in a retrospective observational cohort. We observed that ART initiation 7 days or less ( n = 817) and 8-30 days ( n = 1009) were the most important factors with viral suppression, and had similar viral suppression rate, CD4 + T-cell count increase and fractions of individuals with links at least 4 and individuals linked to recent HIV infection in HIV molecular networks. This study provides real-world evidence on the benefits of rapid ART initiation in resource-limited setting.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • CD4 Lymphocyte Count
  • Cohort Studies
  • HIV Infections* / diagnosis
  • HIV Infections* / drug therapy
  • Humans
  • Retrospective Studies
  • Viral Load

Substances

  • Anti-HIV Agents